These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 26703191)

  • 1. Plasma membrane lipids and their role in fungal virulence.
    Rella A; Farnoud AM; Del Poeta M
    Prog Lipid Res; 2016 Jan; 61():63-72. PubMed ID: 26703191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingolipids: Regulators of azole drug resistance and fungal pathogenicity.
    Song J; Liu X; Li R
    Mol Microbiol; 2020 Dec; 114(6):891-905. PubMed ID: 32767804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal Biofilms: Update on Resistance.
    Borghi E; Borgo F; Morace G
    Adv Exp Med Biol; 2016; 931():37-47. PubMed ID: 27115411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies.
    Mota Fernandes C; Del Poeta M
    Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1083-1092. PubMed ID: 32673125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and prospects for targeting Hsp90 to treat fungal infections.
    Veri A; Cowen LE
    Parasitology; 2014 Aug; 141(9):1127-37. PubMed ID: 24560124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingolipids as targets for treatment of fungal infections.
    Rollin-Pinheiro R; Singh A; Barreto-Bergter E; Del Poeta M
    Future Med Chem; 2016 Aug; 8(12):1469-84. PubMed ID: 27502288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raft-like membrane domains in pathogenic microorganisms.
    Farnoud AM; Toledo AM; Konopka JB; Del Poeta M; London E
    Curr Top Membr; 2015; 75():233-68. PubMed ID: 26015285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heteroresistance and fungi.
    Ferreira GF; Santos DA
    Mycoses; 2017 Sep; 60(9):562-568. PubMed ID: 28660647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highlights in pathogenic fungal biofilms.
    Sardi Jde C; Pitangui Nde S; Rodríguez-Arellanes G; Taylor ML; Fusco-Almeida AM; Mendes-Giannini MJ
    Rev Iberoam Micol; 2014; 31(1):22-9. PubMed ID: 24252828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How do fungal infections "escape" treatment? Resistance and resistance mechanisms].
    Morschhäuser J
    Pharm Unserer Zeit; 2003; 32(2):124-8. PubMed ID: 12677965
    [No Abstract]   [Full Text] [Related]  

  • 11. Fungal biofilm composition and opportunities in drug discovery.
    Reichhardt C; Stevens DA; Cegelski L
    Future Med Chem; 2016 Aug; 8(12):1455-68. PubMed ID: 27485639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting virulence: a new paradigm for antifungals.
    Gauwerky K; Borelli C; Korting HC
    Drug Discov Today; 2009 Feb; 14(3-4):214-22. PubMed ID: 19152839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosomatid and fungal glycolipids and sphingolipids as infectivity factors and potential targets for development of new therapeutic strategies.
    Suzuki E; Tanaka AK; Toledo MS; Levery SB; Straus AH; Takahashi HK
    Biochim Biophys Acta; 2008 Mar; 1780(3):362-9. PubMed ID: 17976917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multitude of targets for the immune system and drug therapy in the fungal cell wall.
    Nimrichter L; Rodrigues ML; Rodrigues EG; Travassos LR
    Microbes Infect; 2005 Apr; 7(4):789-98. PubMed ID: 15823515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles in Fungi: Composition and Functions.
    de Toledo Martins S; Szwarc P; Goldenberg S; Alves LR
    Curr Top Microbiol Immunol; 2019; 422():45-59. PubMed ID: 30242512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sterol-rich plasma membrane domains in fungi.
    Alvarez FJ; Douglas LM; Konopka JB
    Eukaryot Cell; 2007 May; 6(5):755-63. PubMed ID: 17369440
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of Mediator in virulence and antifungal drug resistance in pathogenic fungi.
    Moran GP; Anderson MZ; Myers LC; Sullivan DJ
    Curr Genet; 2019 Jun; 65(3):621-630. PubMed ID: 30637479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal Extracellular Vesicles with a Focus on Proteomic Analysis.
    Bleackley MR; Dawson CS; Anderson MA
    Proteomics; 2019 Apr; 19(8):e1800232. PubMed ID: 30883019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Control of Fungal Cell Walls: Models and Relevance in Fungal Pathogens.
    Koch B; Traven A
    Curr Top Microbiol Immunol; 2020; 425():277-296. PubMed ID: 31807895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles as Vehicles for the Delivery of Biologically Active Fungal Molecules.
    Herkert PF; Amatuzzi RF; Alves LR; Rodrigues ML
    Curr Protein Pept Sci; 2019; 20(10):1027-1036. PubMed ID: 31142247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.